Serum acute phase proteins as clinical phase indicators and outcome predictors in naturally occurring canine monocytic ehrlichiosis

Journal of Veterinary Internal Medicine

Volumn 25, Issue 4, 2011, Pages 811-817

  Mylonakis, Mathios E ^a   Ceron, J J ^b   Leontides, L ^c   Siarkou, V I ^a   Martinez, S ^b   Tvarijonaviciute, A ^b   Koutinas, A F ^a   Harrus, S ^d  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITY OF THESSALY   (Greece)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Dog; Ehrlichia canis; Prognosis

Indexed keywords

C REACTIVE PROTEIN; HAPTOGLOBIN; SERUM ALBUMIN; SERUM AMYLOID A;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EHRLICHIA CANIS; EHRLICHIOSIS; FEMALE; IMMUNOLOGY; MALE; MICROBIOLOGY; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ANIMALS; C-REACTIVE PROTEIN; DOG DISEASES; DOGS; EHRLICHIA CANIS; EHRLICHIOSIS; FEMALE; HAPTOGLOBINS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SERUM AMYLOID A PROTEIN;

ANIMALIA; CANIS FAMILIARIS; EHRLICHIA; EHRLICHIA CANIS; EHRLICHIA SP.; IXODIDA;

EID: 79960557140     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.0728.x     Document Type: Article

References (32)

1. Neer TM, Breitschwerdt EB, Green RT, et al. Consensus statement on ehrlichial diseases of small animals from the infectious disease study group of the ACVIM. J Vet Intern Med 2002;16:309-315.
2. Harrus S, Waner T, Aizenberg I, et al. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis. J Clin Microbiol 1998;36:73-76.
3. Mylonakis ME, Koutinas AF, Breitschwerdt EB, et al. Chronic canine ehrlichiosis (Ehrlichia canis): A retrospective study of 19 natural cases. J Am Anim Hosp Assoc 2004;40:174-184.
4. Mylonakis ME, Siarkou VI, Koutinas AF. Myelosuppressive canine monocytic ehrlichiosis (Ehrlichia canis): An update on the pathogenesis, diagnosis and management. Israel J Vet Med 2010;65:129-135.
5. Harrus S, Kass PH, Klement E, et al. Canine monocytic ehrlichiosis: A retrospective study of 100 cases, and an epidemiological investigation of prognostic indicators for the disease. Vet Rec 1997;141:360-363.
6. Shipov A, Klement E, Reuveni-Tager L, et al. Prognostic indicators for canine monocytic ehrlichiosis. Vet Parasitol 2008;153:131-138.
7. Yamamoto S, Shida T, Miyaji S, et al. Changes in serum C-reactive protein levels in dogs with various disorders and surgical traumas. Vet Res Com 1993;1:85-93.
8. Ceron JJ, Eckersal PD, Martinez-Subiela S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Vet Clin Pathol 2005;34:85-99.
9. Yamamoto S, Shida T, Okimura T, et al. Determination of C-reactive protein in serum and plasma from healthy dogs and dogs with pneumonia by ELISA and slide reversed passive latex agglutination test. Vet Q 1994;16:74-77.
10. Eckersall PD. The time is right for acute phase protein assays. Vet J 2004;168:3-5.
11. Murata H, Shimada N, Yosioka M. Current research on acute phase proteins in veterinary diagnosis: An overview. Vet J 2004;168:28-40.
12. Tecles F, Spiranelli E, Bonfanti U, et al. Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog. J Vet Intern Med 2005;19:865-870.
13. Rikihisa Y, Yamamoto S, Kwak I, et al. C-reactive protein and α1-acid glycoprotein levels in dogs infected with Ehrlichia canis. J Clin Microbiol 1994;32:912-917.
14. Shimada T, Ishida Y, Shimizu M, et al. Monitoring C-reactive protein in Beagle dogs experimentally inoculated with Ehrlichia canis. Vet Res Commun 2002;26:171-177.
15. Mylonakis ME, Leontides L, Gonen L, et al. Anti-Hepatozoon canis serum antibodies and gamonts in naturally-occurring canine monocytic ehrlichiosis. Vet Parasitol 2005;129:229-233.
16. Siarkou VI, Mylonakis ME, Bourtzi-Hatzopoulou E, Koutinas AF. Sequence and phylogenetic analysis of the 16S rRNA gene of Ehrlichia canis strains in dogs with clinical monocytic ehrlichiosis. Vet Microbiol 2007;125:304-12.
17. Martinez-Subiela S, Ceron JJ. Validation of commercial assays for the determination of haptoglobin, C-reactive protein and serum amyloid A in dogs. Archivos de Medicina Veterinaria 2005;37:61-66.
18. Neer TM, Harrus S. Canine monocytotropic ehrlichiosis and neorickettsiosis (E. canis, E. chaffeensis, E. ruminantium, N. sennetsu, and N. risticii infections). In: Green CE, ed. Infectious Diseases of the Dog and Cat. St Louis, MO: Saunders Elsevier; 2006:203-216.
19. Harrus S, Waner T, Avidar Y, et al. Serum protein alterations in canine ehrlichiosis. Vet Parasitol 1996;66:241-249.
20. Martinez-Subiela S, Tecles F, Eckersall PD, et al. Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec 2002;150:241-244.
21. Martinez-Subiela S, Ceron JJ. Evaluation of acute phase protein indexes in dogs with leishmaniasis at diagnosis, during and after short-term treatment. Vet Med-Chech 2005;50:39-46.
22. Stockham SL, Scott MA. Proteins. In: Stockham SL, Scott MA, eds. Fundamentals of Veterinary Clinical Pathology. Ames, IA: Blackwell Publishing; 2008:369-413.
23. Matijatko V, Mrljak V, Kis I, et al. Evidence of an acute phase response in dogs naturally infected with Babesia canis. Vet Parasitol 2007;144:242-250.
24. Yule TD, Roth MB, Dreier K, et al. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine 1997;15:20-29.
25. Mastrorilli C, Dondi F, Agnoli C, et al. Clinicopathologic features and outcome predictors of Leptospira interogans Australis serogroup infection in dogs: A retrospective study of 20 cases (2001-2004). J Vet Intern Med 2007;21:3-10.
26. Holm JL, Rosanski EA, Freeman LM, et al. C-reactive protein concentrations in dogs with acute pancreatitis. J Vet Emerg Crit Care 2004;14:183-186.
27. Gebhardt C, Hirschberger J, Rau S, et al. Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care Med 2009;19:450-458.
28. Mitchell KD, Kruth SA, Wood RD, et al. Serum acute phase protein concentrations in dogs with autoimmune haemolytic anemia. J Vet Intern Med 2009;23:585-591.
29. Kocaturk M, Martinez S, Eralp O, et al. Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis. J Small Anim Pract 2010;51:478-483.
30. Ishikawa S, Kayaba K, Gotoh T, et al. Comparison of C-reactive protein levels between serum and plasma samples on long-term frozen storage after a 13.8 year interval: The JMS cohort study. J Epidemiol 2007;17:120-124.
31. O'Donnell A, Fowkes FJI, Allen SJ, et al. The acute phase response in children with mild and severe malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 2009;103:679-686.
32. Rilley RF, Zontine W. Further observations on the properties of dog C-reactive protein and the C-reactive protein response in the dog. J Lab Clin Med 1972;80:698-703.